- £90.57m
- £761.63m
- $63.03m
- 53
- 92
- 15
- 52
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 60.6 | 58 | 48.5 | 53.7 | 63 |
Cost of Revenue | |||||
Gross Profit | 54.4 | 54.1 | 45.6 | 46.9 | 55.7 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 7.32 | 4.59 | 4.05 | 7.77 | 8.28 |
Operating Profit | 53.3 | 53.4 | 44.5 | 45.9 | 54.8 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 53.9 | 53.1 | 44.1 | 46 | 54.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 37.5 | 49.1 | 27.9 | 35.2 | 30.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 37.5 | 49.1 | 27.9 | 35.2 | 30.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 37.5 | 49.1 | 27.9 | 35.2 | 30.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.205 | 0.268 | 0.153 | 0.192 | 0.169 |